193 related articles for article (PubMed ID: 2151061)
1. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters.
Simon VC; Simon M
Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061
[TBL] [Abstract][Full Text] [Related]
2. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
3. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of fusidic acid in combination with various antibiotics against Staphylococcus epidermidis].
Fosse T; Appert A; Delpech D; Laffont C
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):621-5. PubMed ID: 3054737
[TBL] [Abstract][Full Text] [Related]
5. Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
Roussel-Delvallez M; Wallet F; Barbiery P; Courcol RJ
J Chemother; 1997 Feb; 9(1):5-8. PubMed ID: 9106011
[TBL] [Abstract][Full Text] [Related]
6. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms.
Tang HJ; Chen CC; Cheng KC; Toh HS; Su BA; Chiang SR; Ko WC; Chuang YC
J Antimicrob Chemother; 2012 Apr; 67(4):944-50. PubMed ID: 22258931
[TBL] [Abstract][Full Text] [Related]
8. Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters.
Pascual A; Ramirez de Arellano E; Perea EJ
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):515-7. PubMed ID: 7957277
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
10. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
[TBL] [Abstract][Full Text] [Related]
12. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Aepfelbacher M
MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
[TBL] [Abstract][Full Text] [Related]
13. Adverse effect of staphylococci slime on in vitro activity of glycopeptides.
Mathur T; Singhal S; Khan S; Upadhyay D; Fatma T; Rattan A
Jpn J Infect Dis; 2005 Dec; 58(6):353-7. PubMed ID: 16377866
[TBL] [Abstract][Full Text] [Related]
14. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.
Barr JG; Smyth ET; Hogg GM
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):804-9. PubMed ID: 2150814
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB
J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959
[TBL] [Abstract][Full Text] [Related]
16. [Sensitivity curves of multiply resistant corynebacteria JK and D2].
Rauturier M; Darbas H; Jean-Pierre H; Boyer G; Rivière M
Pathol Biol (Paris); 1990 May; 38(5):420-5. PubMed ID: 2142275
[TBL] [Abstract][Full Text] [Related]
17. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
[TBL] [Abstract][Full Text] [Related]
18. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
Reynaud AE; Espaze EP; Coste-Burel M; Richet H
Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828
[TBL] [Abstract][Full Text] [Related]
19. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M
Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
